Description of event according to study: at the index procedure on (b)(6) 2015 the patient received a celect filter.The inferior vena cava (ivc) diameter at the intended filter location was 25.0 mm.There was no ivc anatomic anomaly or presence of thrombus in the ivc prior to filter placement.Using the right common femoral vein as the access site, a celect filter was deployed at the intended location in the ivc infrarenal site and in a location suitable to provide sufficient mechanical protection against pe.The filter neither deployed prematurely nor did the filter jump upon deployment.There was no evidence of filter fracture, deformation, or migration.There was no extravasation of contrast or filter legs appearing outside the column of contrast after filter placement.The angle of filter tilt was 11-<16 degrees.Analysis of the placement procedure venacavagram revealed no ivc anatomic anomaly or presence of thrombus in the ivc prior to filter placement.The filter placement site was infrarenal, and the ivc diameter at the filter location was 22.2.There was no evidence of filter migration, extravasation of contrast, or deformation.Filter leg(s) did appear outside the column of contrast after filter placement.From the venacavagram, the angle of filter tilt in the ap view was 2.4 degrees.On (b)(6) 2015 (day of procedure), the post- procedure x-ray was completed.Site report of tilt was 0 degrees.Analysis revealed filter tilt of 15.6 degrees in the ap view and 16 degrees in the oblique view.On (b)(6) 2016 (375 days post-procedure), the 12-month follow-up ct scan was performed and the site indicated no filter embolization and no filter leg interaction with the ivc wall.Analysis of the ct scan revealed 11 filter legs with grade 1 interaction with the ivc wall and 1 filter leg with grade 3 interaction with the ivc wall.The organ affected was the iliac artery.There was no hemorrhage, hematoma, or other clinical findings observed at the perforation/puncture site.On (b)(6) 2016 (429 days post-procedure), the 12-month follow-up clinical assessment was completed.The site indicated that due to ongoing risk for pe, the filter would not be removed.Patient outcome: the patient remains in the study.
|